Trial Profile
A single-centre, randomised, split-face, subject- and rater-blinded crossover study comparing the efficacy of incobotulinumtoxinA and onabotulinumtoxinA in subjects with crow's feet
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Therapeutic Use
- 03 Nov 2015 New trial record